38066
ACIBADEM CITY CLINIC B.V.
Dec 7, 2016
Bulgaria
Europe
Mar 28, 2025
B - Limited
Completed
Approved : Feb 9, 2017
Signed : Apr 19, 2017
Invested : May 10, 2017
Hospitals and Clinics
Health, Education and Life Sciences
Regional Industry MAS LAC & EUR
Acibadem Health Group (“AHG” or the “sponsor” - http://www.acibademinternational.com) is a prominent hospital group in Turkey, 60 percent owned by IHH Healthcare Berhad, a Malaysia-based healthcare and medical education company with operations in eight countries across Asia, Central and Eastern Europe, Middle East and North Africa. AHG’s 15 percent are indirectly held by Bagan Lalang Ventures Sdn Bhd, a subsidiary of Khazanah Nasional Berhad, a Malaysian sovereign fund. The remaining 25 percent is held by the founding shareholder, Mehmet Ali Aydinlar and family.
AHG operates 16 hospitals and 13 medical centers in Turkey with 17,000 employees of whom 2,600 are medical doctors. AHG’s first foreign investment took place in 2011, with the acquisition of 32 percent share of Sistina Hospital in Skopje, Macedonia. AHG also provides management services to Faruk Medical City in Erbil, Iraq.
AHG invited IFC to invest in Acibadem City Clinic B.V., a Special Purpose Vehicle (“SPV” or “AHG Bulgaria” or the “Company”) established by AHG, its subsidiary Acibadem Sistina (“Sistina”) and several existing shareholders of City Clinic, a healthcare company in Bulgaria operating three hospitals and one clinic in Sofia, Varna and Burgas to acquire Tokuda Hospital Group running the largest hospital including an outpatient clinic and a small insurance business in Bulgaria. The total project cost is estimated at $111 million (equivalent to EUR 100 million) and IFC is considering an up to $16.7 million (equivalent to EUR 15 million) straight equity investment into AHG Bulgaria.
AHG Bulgaria will be comprised of City Clinic hospitals (a 84-bed Cardiovascular Hospital and an outpatient clinic in Sofia covering 4,700 m2 area operational since 2012, an 80-bed Oncology Hospital in Sofia covering 10,700 m2 area operational since 2015, an outpatient clinic in Varna covering 2,300 m2 area, part of the group since 2011, a 31-bed Cardiology Center in Burgas covering 1,396 m2 area operational since 2011 acquired on July 2015; and Tokuda Hospital Group entities including 560-bed Tokuda Hospital in Sofia (covering 55,000 m2 area operational since 2006), Tokuda Medical Center (MC Tokuda), an outpatient clinic operating as separate entity within Tokuda Hospital.
The scope of IFC environment and social (E&S) review included assessment of the shareholder companies’ capacity to provide oversight and monitor compliance with IFC’s Performance Standards (PS's) as well as local environmental, social and occupational health and safety regulatory requirements for its operations.
As the transaction took place recently, AHG Bulgaria’s E&S policies and systems are still being developed as the new shareholders are currently reviewing the E&S policies and procedures for City Clinic and Tokuda Hospital Group. Therefore, IFC technical experts’ review relied on documents and reports made available by respective companies, i.e. AHG, City Clinic and Tokuda Hospital, as well as interviews conducted during separate meetings and site visits on May 6, 2016 in Istanbul and between 9 and 12 of May, 2016 in Sofia. The IFC team visited AHG’s headquarter in Istanbul (Turkey), two City Clinic facilities (Cardiovascular and Oncology hospitals), and Tokuda hospital in Sofia.
IFC team conducted meetings and interviews with key management personnel including: AHG’s department heads and staff of business development, human resources and technical services; City Clinic’s chief executive officer, environmental and technical consultant and department managers of human resources and medical services; and Tokuda Hospital’s manager and department heads and staff of finance, legal, human resources, clinics and technical services.